Antibiotic-Resistant Gonorrhea

Related Pages
media iconLow Resolution Video

Basic Information
'Basic Information' graphic stating, 'Little now stands between us and untreatable gonorrhea'.

Laboratory Information
'Laboratory Information' graphic showing how resistance is going up while new drugs are declining.

Combating the Threat
'Combating the Threat' graphic showing illustration of a man taking medication.

Gonorrhea has progressively developed resistance to the antibiotic drugs prescribed to treat it. Following the spread of gonococcal fluoroquinolone resistance, the cephalosporin antibiotics have been the foundation of recommended treatment for gonorrhea. The emergence of cephalosporin-resistant gonorrhea would significantly complicate the ability of providers to treat gonorrhea successfully, since we have few antibiotic options left that are simple, well-studied, well-tolerated and highly effective. It is critical to continuously monitor antibiotic resistance in Neisseria gonorrhoeae and encourage research and development of new treatment regimens.

Updates

Gonococcal Isolate Surveillance Project (GISP) Profiles 2017 (April 2019)

AR Investment Map This interactive tool shows CDC’s key investments to combat antibiotic resistance (AR), including resistant gonorrhea, across the nation.

Related Resources

ARG Infographic

ARG Infographics

Antibiotic Resistance Solutions Initiative

Antibiotic Resistance Solutions Initiative

AMD in Action - CDC responds to the urgent threat of antimicrobial-resistant gonorrhea. Learn more.

Advanced Molecular Detection (AMD)

Improving Antibiotic Use to Treat Gonorrhea

Improving Antibiotic Use to Treat Gonorrhea

Page last reviewed: October 24, 2019
Content source: Division of STD Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention